These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 37088992)
1. METTL3 affects FLT3-ITD+ acute myeloid leukemia by mediating autophagy by regulating PSMA3-AS1 stability. Wu S; Weng S; Zhou W; Chen Y; Liu Z Cell Cycle; 2023 May; 22(10):1232-1245. PubMed ID: 37088992 [TBL] [Abstract][Full Text] [Related]
2. IGF2BP2 promotes lncRNA DANCR stability mediated glycolysis and affects the progression of FLT3-ITD + acute myeloid leukemia. Wu S; Chi C; Weng S; Zhou W; Liu Z Apoptosis; 2023 Aug; 28(7-8):1035-1047. PubMed ID: 37060505 [TBL] [Abstract][Full Text] [Related]
3. Chidamide inhibits cell glycolysis in acute myeloid leukemia by decreasing N6-methyladenosine-related GNAS-AS1. Hu C; Fu X; Li S; Chen C; Zhao X; Peng J Daru; 2024 Jun; 32(1):11-24. PubMed ID: 37926762 [TBL] [Abstract][Full Text] [Related]
4. Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia. Alachkar H; Santhanam R; Harb JG; Lucas DM; Oaks JJ; Hickey CJ; Pan L; Kinghorn AD; Caligiuri MA; Perrotti D; Byrd JC; Garzon R; Grever MR; Marcucci G J Hematol Oncol; 2013 Mar; 6():21. PubMed ID: 23497456 [TBL] [Abstract][Full Text] [Related]
5. YY1-induced long non-coding RNA PSMA3 antisense RNA 1 functions as a competing endogenous RNA for microRNA 214-5p to expedite the viability and restrict the apoptosis of bladder cancer cells via regulating programmed cell death-ligand 1. Zhang M; Xu Y; Yin S; Qiu F Bioengineered; 2021 Dec; 12(2):9150-9161. PubMed ID: 34720049 [TBL] [Abstract][Full Text] [Related]
6. ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia. Hwang DY; Eom JI; Jang JE; Jeung HK; Chung H; Kim JS; Cheong JW; Min YH J Exp Clin Cancer Res; 2020 May; 39(1):85. PubMed ID: 32393312 [TBL] [Abstract][Full Text] [Related]
7. lncRNA PSMA3-AS1 promotes the progression of non-small cell lung cancer through targeting miR-17-5p/PD-L1. Cheng G; Li Y; Liu Z; Song X Adv Clin Exp Med; 2021 Oct; 30(10):1043-1050. PubMed ID: 34610219 [TBL] [Abstract][Full Text] [Related]
8. Targeting lncRNA PSMA3-AS1, a Prognostic Marker, Suppresses Malignant Progression of Oral Squamous Cell Carcinoma. Cao X; Luan K; Yang J; Huang Y Dis Markers; 2021; 2021():3138046. PubMed ID: 34457087 [TBL] [Abstract][Full Text] [Related]
9. CALCRL knockdown suppresses cancer stemness and chemoresistance in acute myeloid leukemia with FLT3-ITD and DNM3TA-R882 double mutations. Tang S; Zhu H; Sheng L; Mu Q; Wang Y; Xu K; Zhou M; Xu Z; Wu A; Ouyang G Drug Dev Res; 2024 Feb; 85(1):e22137. PubMed ID: 38349260 [TBL] [Abstract][Full Text] [Related]
10. Long Noncoding RNA SOCS2-AS Promotes Leukemogenesis in FLT3-ITD+ Acute Myeloid Leukemia Through miRNA-221. Zhang R; Huo CH Onco Targets Ther; 2020; 13():2925-2934. PubMed ID: 32308425 [TBL] [Abstract][Full Text] [Related]
11. Long Noncoding RNA PSMA3 Antisense RNA 1 Promotes Cell Proliferation, Migration, and Invasion in Pancreatic Ductal Adenocarcinoma Via Targeting MicroRNA-154-5p to Positively Modulate Karyopherin Subunit Alpha 4. Bi J; Liang W; Wang Y; Tian W; Cao S; Liu P Pancreas; 2022 Sep; 51(8):1037-1046. PubMed ID: 36607951 [TBL] [Abstract][Full Text] [Related]
12. Penfluridol triggers cytoprotective autophagy and cellular apoptosis through ROS induction and activation of the PP2A-modulated MAPK pathway in acute myeloid leukemia with different FLT3 statuses. Wu SY; Wen YC; Ku CC; Yang YC; Chow JM; Yang SF; Lee WJ; Chien MH J Biomed Sci; 2019 Aug; 26(1):63. PubMed ID: 31470848 [TBL] [Abstract][Full Text] [Related]
13. Over-expression of FoxM1 is associated with adverse prognosis and FLT3-ITD in acute myeloid leukemia. Liu LL; Zhang DH; Mao X; Zhang XH; Zhang B Biochem Biophys Res Commun; 2014 Mar; 446(1):280-5. PubMed ID: 24582753 [TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA PSMA3-AS1 promotes glioma progression through modulating the miR-411-3p/HOXA10 pathway. Huang T; Chen Y; Zeng Y; Xu C; Huang J; Hu W; Chen X; Fu H BMC Cancer; 2021 Jul; 21(1):844. PubMed ID: 34294084 [TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA SBF2-AS1 act as a ceRNA to modulate cell proliferation via binding with miR-188-5p in acute myeloid leukemia. Tian YJ; Wang YH; Xiao AJ; Li PL; Guo J; Wang TJ; Zhao DJ Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1730-1737. PubMed ID: 31062614 [TBL] [Abstract][Full Text] [Related]
16. A novel circular RNA (hsa_circ_0000370) increases cell viability and inhibits apoptosis of FLT3-ITD-positive acute myeloid leukemia cells by regulating miR-1299 and S100A7A. Zhang L; Bu Z; Shen J; Shang L; Chen Y; Wang Y Biomed Pharmacother; 2020 Feb; 122():109619. PubMed ID: 31919040 [TBL] [Abstract][Full Text] [Related]
17. Proteasome inhibitors induce FLT3-ITD degradation through autophagy in AML cells. Larrue C; Saland E; Boutzen H; Vergez F; David M; Joffre C; Hospital MA; Tamburini J; Delabesse E; Manenti S; Sarry JE; Récher C Blood; 2016 Feb; 127(7):882-92. PubMed ID: 26286850 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of the proteasome and proteaphagy enhances apoptosis in FLT3-ITD-driven acute myeloid leukemia. Lopez-Reyes RG; Quinet G; Gonzalez-Santamarta M; Larrue C; Sarry JE; Rodriguez MS FEBS Open Bio; 2021 Jan; 11(1):48-60. PubMed ID: 33410599 [TBL] [Abstract][Full Text] [Related]
19. miR-155 promotes FLT3-ITD-induced myeloproliferative disease through inhibition of the interferon response. Wallace JA; Kagele DA; Eiring AM; Kim CN; Hu R; Runtsch MC; Alexander M; Huffaker TB; Lee SH; Patel AB; Mosbruger TL; Voth WP; Rao DS; Miles RR; Round JL; Deininger MW; O'Connell RM Blood; 2017 Jun; 129(23):3074-3086. PubMed ID: 28432220 [TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA PSMA3-AS1 promotes malignant phenotypes of esophageal cancer by modulating the miR-101/EZH2 axis as a ceRNA. Qiu BQ; Lin XH; Ye XD; Huang W; Pei X; Xiong D; Long X; Zhu SQ; Lu F; Lin K; Zhang XQ; Xu JJ; Sheng LL; Zhang XM; Zhang PF; Wu YB Aging (Albany NY); 2020 Jan; 12(2):1843-1856. PubMed ID: 32005028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]